BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8633194)

  • 1. Sharing of four DR-beta sequence motifs between HLA-DRB1*1601 and DRB1*1101 correlates with frequent degenerate T-cell recognition of HA306-320 peptide complexed to these two molecules.
    Zeliszewski D; Dorval I; Golvano JJ; Prevost A; Borras-Cuesta F; Sterkers G
    Scand J Immunol; 1996 Feb; 43(2):146-54. PubMed ID: 8633194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of ALA-substituted analogs of HA306-320 to DR1101, DR1301, and DR0402 molecules: correlation of DR-peptide interactions with recognition by a single TCR.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Borras-Cuesta F; Sterkers G
    Hum Immunol; 1996 Sep; 50(1):61-9. PubMed ID: 8872176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR molecules.
    Zeliszewski D; Gaudebout P; Golvano JJ; Dorval I; Prévost A; Borras-Cuesta F; Sterkers G
    Hum Immunol; 1994 Sep; 41(1):28-33. PubMed ID: 7836061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single residue polymorphism at DR beta 37 affects recognition of peptides by T cells.
    Chen YZ; Matsushita S; Nishimura Y
    Hum Immunol; 1997 Apr; 54(1):30-9. PubMed ID: 9154455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic recognition of HLA-DRB1*0406 by T cells with HLA-DRB1*0403: role of amino acid residue 37 on the beta sheet in T cell recognition.
    Kaneko T; Obata F
    Immunobiology; 1996 Aug; 195(3):261-70. PubMed ID: 8877401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
    Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
    J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.
    Chow IT; James EA; Gates TJ; Tan V; Moustakas AK; Papadopoulos GK; Kwok WW
    J Immunol; 2013 May; 190(9):4516-24. PubMed ID: 23543758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific variation in the degeneracy of major histocompatibility complex (MHC) restriction.
    Carmichael P; Copier J; So A; Lechler R
    Hum Immunol; 1997 Apr; 54(1):21-9. PubMed ID: 9154454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of T cell receptor V beta elements by HLA-DR determinants predisposing to rheumatoid arthritis.
    Weyand CM; Oppitz U; Hicok K; Goronzy JJ
    Arthritis Rheum; 1992 Sep; 35(9):990-8. PubMed ID: 1384516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones.
    Zanni MP; von Greyerz S; Schnyder B; Wendland T; Pichler WJ
    Int Immunol; 1998 Apr; 10(4):507-15. PubMed ID: 9620607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of a myelin basic protein-specific human T cell clone by antigen-presenting cells from rhesus monkeys.
    Meinl E; t Hart BA; Bontrop RE; Hoch RM; Iglesias A; de Waal Malefyt R; Fickenscher H; Müller-Fleckenstein I; Fleckenstein B; Wekerle H
    Int Immunol; 1995 Sep; 7(9):1489-95. PubMed ID: 7495756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes.
    Sun JY; Senitzer D; Forman SJ; Chatterjee S; Wong KK
    Cancer Immunol Immunother; 2003 Dec; 52(12):761-70. PubMed ID: 14564482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of TCR-alpha beta sequences of cross-reactive anti-DR alloreactive T-cell clones: identification of possible contact residues based on charge complementarity between TCR chains and DR determinants.
    Champagne E; Essaket S; Huchenq A; Fabron J; Coppin HL; Sevin J; Thomsen M
    Eur J Immunogenet; 1992; 19(1-2):21-31. PubMed ID: 1533151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.
    Ou D; Mitchell LA; Décarie D; Tingle AJ; Nepom GT
    Hum Immunol; 1998 Mar; 59(3):149-57. PubMed ID: 9548074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DR-restricted T-cell reactivities associated with the Dw19 specificity can be directed against the products of either locus DRB3 (DRw52c) or locus DRB1.
    Zeliszewski D; Tiercy JM; Dorval I; Kaplan C; Mach B; Sterkers G
    Hum Immunol; 1990 Aug; 28(4):345-53. PubMed ID: 2391250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.